553 related articles for article (PubMed ID: 17567733)
21. Pharmacokinetics and metabolism of a RAS farnesyl transferase inhibitor in rats and dogs: in vitro-in vivo correlation.
Singh R; Chen IW; Jin L; Silva MV; Arison BH; Lin JH; Wong BK
Drug Metab Dispos; 2001 Dec; 29(12):1578-87. PubMed ID: 11717177
[TBL] [Abstract][Full Text] [Related]
22. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
23. Disposition and metabolism of indeloxazine hydrochloride, a cerebral activator, in rats.
Kamimura H; Enjoji Y; Sasaki H; Kawai R; Kaniwa H; Niigata K; Kageyama S
Xenobiotica; 1987 Jun; 17(6):645-58. PubMed ID: 3630201
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
25. Disposition and metabolism of 14C-rifapentine in healthy volunteers.
Reith K; Keung A; Toren PC; Cheng L; Eller MG; Weir SJ
Drug Metab Dispos; 1998 Aug; 26(8):732-8. PubMed ID: 9698286
[TBL] [Abstract][Full Text] [Related]
26. Metabolism of 14C-estazolam in dogs and humans.
Machinist JM; Bopp BA; Anderson DJ; Granneman GR; Sonders RC; Tolman K; Buchi K; Rollins D
Xenobiotica; 1986 Jan; 16(1):11-20. PubMed ID: 2868576
[TBL] [Abstract][Full Text] [Related]
27. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
[TBL] [Abstract][Full Text] [Related]
28. Absorption, metabolism and excretion of ketanserin in man after oral administration.
Meuldermans W; Hendrickx J; Woestenborghs R; Van Peer A; Lauwers W; De Cree J; Heykants J
Arzneimittelforschung; 1988 Jun; 38(6):789-94. PubMed ID: 3178919
[TBL] [Abstract][Full Text] [Related]
29. Biotransformation and elimination of 14C-flecainide acetate in humans.
McQuinn RL; Quarfoth GJ; Johnson JD; Banitt EH; Pathre SV; Chang SF; Ober RE; Conard GJ
Drug Metab Dispos; 1984; 12(4):414-20. PubMed ID: 6148206
[TBL] [Abstract][Full Text] [Related]
30. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
[TBL] [Abstract][Full Text] [Related]
31. The disposition and metabolic fate of 14C-cibenzoline in man.
Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
[TBL] [Abstract][Full Text] [Related]
32. Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat.
Matsui K; Mishima M; Nagai Y; Yuzuriha T; Yoshimura T
Drug Metab Dispos; 1999 Dec; 27(12):1406-14. PubMed ID: 10570021
[TBL] [Abstract][Full Text] [Related]
33. Metabolism and pharmacokinetics of 14C-pentoxifylline in healthy volunteers.
Bryce TA; Chamberlain J; Hillbeck D; Macdonald CM
Arzneimittelforschung; 1989 Apr; 39(4):512-7. PubMed ID: 2751739
[TBL] [Abstract][Full Text] [Related]
34. The absorption, metabolism and excretion of (14C)-AR-L 115 BS in the baboon.
Cameron BD; Draffan GH; Dunsire JP; Zimmer A
Arzneimittelforschung; 1981; 31(1a):217-20. PubMed ID: 7195225
[TBL] [Abstract][Full Text] [Related]
35. Biotransformation of the novel inotropic agent toborinone (OPC-18790) in rats and dogs. Evidence for the formation of novel glutathione and two cysteine conjugates.
Kitani M; Miyamoto G; Nagasawa M; Yamada T; Matsubara J; Uchida M; Odomi M
Drug Metab Dispos; 1997 Jun; 25(6):663-74. PubMed ID: 9193867
[TBL] [Abstract][Full Text] [Related]
36. Mass Balance and Metabolic Pathways of Eliapixant, a P2X3 Receptor Antagonist, in Healthy Male Volunteers.
Reif S; Schultze-Mosgau MH; Engelen A; Piel I; Denner K; Roffel A; Tiessen R; Klein S; Francke K; Rottmann A
Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):71-85. PubMed ID: 38044419
[TBL] [Abstract][Full Text] [Related]
37. Disposition and metabolic fate of 14C-quazepam in man.
Zampaglione N; Hilbert JM; Ning J; Chung M; Gural R; Symchowicz S
Drug Metab Dispos; 1985; 13(1):25-9. PubMed ID: 2858372
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of the calcium antagonist gallopamil in man.
Weymann J; Bühler V; Hege HG; Müller-Peltzer H; Schenk G; Stieren B; Hollmann M
Arzneimittelforschung; 1989 May; 39(5):605-7. PubMed ID: 2757679
[TBL] [Abstract][Full Text] [Related]
39. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
[TBL] [Abstract][Full Text] [Related]
40. The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects.
Möller A; Iwasaki K; Kawamura A; Teramura Y; Shiraga T; Hata T; Schäfer A; Undre NA
Drug Metab Dispos; 1999 Jun; 27(6):633-6. PubMed ID: 10348790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]